Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Bevacizumab plus erlotinib in advanced solid cancers with Krebs cycle gene mutations: A multicenter phase II study (BRISK; KCSG AL22-16)Hyehyun Jeong, Changhoon Yoo, Shinkyo Yoon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2019
Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancerHyo Song Kim, Woong Sub Koom, Song-Ee Baek, et al.
JHEP Reports : Innovation in Hepatology|December 1, 2025
Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN studyPasquale Lombardi, Jung Sun Kim, Giulia F Manfredi, et al.
Journal of Gastric Cancer|January 17, 2025
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline)In-Ho Kim, Seung Joo Kang, Wonyoung Choi, et al.
Hepatology (Baltimore, Md.)|December 7, 2024
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapyBernhard Scheiner, Beodeul Kang, Lorenz Balcar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 12, 2025
Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International CentersMargherita Rimini, Lorenzo Fornaro, Masafumi Ikeda, et al.
Liver Cancer|October 9, 2025
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse StudyAlessandro Vitale, Jung Sun Kim, Giuseppe Cabibbo, et al.
Pageof 10